Cholesterol, high-density lipoprotein, and glucose index
1 paper1 finding
- Humans1
Associations
1Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 4.46
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 4.46
Cholesterol, high-density lipoprotein, and glucose index raises the risk of metabolic dysfunction-associated steatotic liver disease in humans (OR 4.46, 95% CI 3.00-6.64).
Humansin non-diabetic Japanese adultsn = 13,682
Frontiers in nutrition23 Jul 2026
More on Metabolic dysfunction-associated steatotic liver disease
Latest
3 in 12 monthsJournal of Diabetes Investigation
The cholesterol, high-density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new-onset cardiovascular-liver-metabolic multimorbidity: A prospective cohort study
Cohort study of 6,534 peopleCardiovascular disease
Cardiovascular Diabetology
The cholesterol, high-density lipoprotein, and glucose index and its derived indices predict cardiometabolic multimorbidity development and progression in metabolic dysfunction-associated steatotic liver disease individuals: a prospective cohort study
Cohort study of 109,434 peopleCardiometabolic multimorbidity
Frontiers in Nutrition
Exploratory mediation analysis of body roundness index in the nonlinear association between CHG index and metabolic dysfunction-associated steatotic liver disease among non-diabetic adults
Cross-sectional study of 13,682 peopleBody roundness index